Mahesh Krishnan - Mar 18, 2022 Form 3 Insider Report for CHINOOK THERAPEUTICS, INC. (KDNY)

Role
Director
Signature
/s/ Kirk Schumacher, Attorney-in-Fact
Stock symbol
KDNY
Transactions as of
Mar 18, 2022
Transactions value $
$0
Form type
3
Date filed
3/29/2022, 05:28 PM
Next filing
Apr 5, 2022

No securities are beneficially owned.

Remarks:

No securities are beneficially owned.